Huberman Lab cover image

Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders

Huberman Lab

CHAPTER

Exploring Ketamine's Therapeutic Potential and its Role in Psychedelic Therapy

This chapter investigates the use of NMDA antagonist psychedelics like ketamine and its intranasal version, Spravato, in therapy for mental health disorders. It contrasts traditional psychedelic therapy with a structured clinical approach, highlighting the importance of therapeutic narratives and the potential for future research in this field.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner